www.fdanews.com/articles/95478-wyeth-begins-marketing-and-distributing-benefix-in-europe
Wyeth Begins Marketing and Distributing BeneFIX in Europe
July 3, 2007
Wyeth Pharmaceuticals, a division of Wyeth announced that it has assumed all marketing and distribution rights toBeneFIX Coagulation Factor IX (Recombinant) in Europe.
JuraForm